Status:
COMPLETED
Language Treatment for Progressive Aphasia
Lead Sponsor:
Baycrest
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Primary Progressive Aphasia
Nonfluent Progressive Aphasia
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Progressive aphasia is characterized by a steady and progressive loss of language skills in the presence of relatively preserved memory, attention, and thinking. The aim of this study is to slow the p...
Eligibility Criteria
Inclusion
- Diagnosis of progressive aphasia
- Native English speaker or fluent in English
- Adequate hearing and vision (not requiring more than +6 diopter correction)
- Willing and able to participate in each phase of the study (including two fMRI sessions)
Exclusion
- Contraindications to fMRI (e.g., claustrophobia, pacemaker, ferromagnetic implant)
- Current medical or psychiatric condition affecting cognition (other than progressive aphasia)
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00957710
Start Date
August 1 2009
End Date
December 1 2010
Last Update
January 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baycrest
Toronto, Ontario, Canada, M6A 2E1